Over the past 12 months, 7 insiders at Lyell Immunopharma, Inc. filed 28 open-market SEC Form 4 transactions on LYEL: 2 purchases worth $25.0M and 26 sales worth $490K. Insiders have been net sellers over this period. The most recent filing was on May 11, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 11, 26 | Veronica Sanchez BulisVP, Corporate Controller | SELL | 217 | $18.91 | $4K |
| Mar 6, 26 | Arch Venture Partners Ix Overage, L.p.TenPercentOwner | BUY | 488.1K | $25.61 | $12.5M |
| Mar 6, 26 | Paul L BernsTenPercentOwner | BUY | 488.1K | $25.61 | $12.5M |
| Feb 11, 26 | Stephen J. HillChief Operating Officer | SELL | 1.2K | $23.39 | $29K |
| Feb 11, 26 | Gary K. LeeChief Scientific Officer | SELL | 1.7K | $23.39 | $39K |
| Feb 11, 26 | Lynn SeelyPresident and CEO | SELL | 7.5K | $23.39 | $174K |
| Feb 10, 26 | Veronica Sanchez BulisVP, Corporate Controller | SELL | 254 | $23.12 | $6K |
| Feb 10, 26 | Stephen J. HillChief Operating Officer | SELL | 109 | $23.12 | $3K |
| Feb 10, 26 | Gary K. LeeChief Scientific Officer | SELL | 147 | $23.12 | $3K |
| Feb 10, 26 | Lynn SeelyPresident and CEO | SELL | 438 | $23.12 | $10K |
| Dec 30, 25 | Veronica Sanchez BulisVP, Corporate Controller | SELL | 936 | $32.32 | $30K |
| Dec 24, 25 | Veronica Sanchez BulisVP, Corporate Controller | SELL | 1.1K | $38.67 | $44K |
| Nov 10, 25 | Veronica Sanchez BulisVP, Corporate Controller | SELL | 239 | $16.10 | $4K |
| Nov 10, 25 | Stephen J. HillChief Operating Officer | SELL | 95 | $16.12 | $2K |
| Nov 10, 25 | Gary K. LeeChief Scientific Officer | SELL | 138 | $16.16 | $2K |
| Nov 10, 25 | Lynn SeelyPresident and CEO | SELL | 412 | $16.11 | $7K |
| Aug 21, 25 | Stephen J. HillChief Operating Officer | SELL | 1.0K | $10.54 | $11K |
| Aug 21, 25 | Gary K. LeeChief Scientific Officer | SELL | 1.5K | $10.54 | $15K |
| Aug 21, 25 | Charles W. NewtonChief Financial Officer | SELL | 1.5K | $10.54 | $15K |
| Aug 21, 25 | Lynn SeelyPresident and CEO | SELL | 7.3K | $10.54 | $76K |
| Aug 12, 25 | Stephen J. HillChief Operating Officer | SELL | 94 | $10.34 | $972 |
| Aug 12, 25 | Gary K. LeeChief Scientific Officer | SELL | 136 | $10.34 | $1K |
| Aug 12, 25 | Charles W. NewtonChief Financial Officer | SELL | 136 | $10.34 | $1K |
| Aug 12, 25 | Lynn SeelyPresident and CEO | SELL | 406 | $10.34 | $4K |
| Aug 11, 25 | Stephen J. HillChief Operating Officer | SELL | 91 | $10.53 | $958 |
| Aug 11, 25 | Gary K. LeeChief Scientific Officer | SELL | 131 | $10.53 | $1K |
| Aug 11, 25 | Charles W. NewtonChief Financial Officer | SELL | 131 | $10.53 | $1K |
| Aug 11, 25 | Lynn SeelyPresident and CEO | SELL | 391 | $10.53 | $4K |
| Mar 31, 25 | Otis W BrawleyDirector | BUY | 35.6K | $0.56 | $20K |
| Mar 21, 25 | Sumant RamachandraDirector | BUY | 200.0K | $0.58 | $116K |
| Mar 17, 25 | Charles W. NewtonChief Financial Officer | BUY | 200.0K | $0.56 | $112K |
| Mar 14, 25 | Richard KlausnerDirector | BUY | 158.0K | $0.60 | $95K |
| Mar 14, 25 | Lynn SeelyPresident and CEO | BUY | 175.0K | $0.61 | $107K |
| Aug 15, 23 | Richard KlausnerDirector | SELL | 58.0K | $2.28 | $132K |
| Sep 23, 22 | Richard KlausnerDirector | SELL | 11.1K | $6.40 | $71K |
Over the past 12 months, insiders at Lyell Immunopharma, Inc. filed 2 open-market purchases worth $25.0M and 26 sales worth $490K on LYEL, which makes them net sellers over the period. The most recent Form 4 was filed on May 11, 26.
The largest recent open-market LYEL insider purchase in our data was $12.5M by Arch Venture Partners Ix Overage, L.p., TenPercentOwner, filed on Mar 6, 26.
7 different insiders at Lyell Immunopharma, Inc. filed open-market SEC Form 4 transactions on LYEL over the last 12 months.
InsiderTape plots every LYEL insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Lyell Immunopharma, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →